An Open-label, Multi-center, Randomized Phase III Study of Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
Who is this study for? Adult patients with thymoma
What treatments are being studied? Adjuvant radiotherapy
Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study is designed to investigate whether adjuvant radiotherapy after complete resection has a better survival for stage II or III thymoma.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• 18\
• 75 years old; Eastern Cooperative Oncology Group performance status of 0 to 2; Pathologically confirmed masaoka stage II or III thymoma; Have adequate bone marrow, hepatic, and renal function; Patients receive complete resection within 3 months; Written informed consent.
Locations
Other Locations
China
Kailiang Wu
RECRUITING
Shanghai
Contact Information
Primary
Kailiang Wu, MD.PhD.
wukailiang@aliyun.com
+86 64175590
Backup
Xingwen Fan, MD
wenxingfan@126.com
+8613651669687
Time Frame
Start Date: 2018-01-10
Estimated Completion Date: 2029-12
Participants
Target number of participants: 238
Treatments
Experimental: radiotherapy group
complete resection and adjuvant radiotherapy
No_intervention: observation group
complete resection
Related Therapeutic Areas
Sponsors
Leads: Fudan University